Statistical mapping analysis of serotonin synthesis images generated in healthy volunteers using positron-emission tomography and α-[ 11C]methyl-L-tryptophan

Journal of Psychiatry and Neuroscience

Volumn 25, Issue 4, 2000, Pages 359-370

  Okazawa, Hidehiko ^a   Leyton, Marco ^b   Benkelfat, Chawki ^b   Mzengeza, Shadreck ^a   Diksic, Mirko ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Brain; Data interpretation, statistical; Magnetic resonance imaging; Radioactive tracers; Serotonin; Sex factors; Tomography, emission computed; Tryptophan

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; SEROTONIN; TRYPTOPHAN;

ADULT; ARTICLE; BIOSYNTHESIS; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SCINTISCANNING; STATISTICS;

ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; SEROTONIN; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED; TRYPTOPHAN;

EID: 0034263229     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Byerley WF, Risch SC. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment. J Clin Psychopharmacol 1985;5:191-206.
2. van Praag HM. Anxiety and aggression as pacemakers of depression: a dimensional variation of the serotonin hypothesis of depression. In: Mendlewicz J, Racagni G, Brunello N, editors. Current therapeutic approaches to panic and other anxiety disorders. Basel (Switzerland): Karger; 1994. p. 144-50.
3. Heninger GH. Indoleamine: the role of serotonin in clinical disorders. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995. p. 471-82.
4. Diksic M, Nagahiro S, Sourkes TL, Yamamoto YL. A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J Cereb Blood Flow Metab 1990;10:1-12.
5. Nagahiro S, Takada A, Diksic M, Sourkes TL, Missala K, Yamamoto YL. A new method to measure brain serotonin synthesis in vivo. II. A practical autoradiographic method tested in normal and lithium-treated rats. J Cereb Blood Flow Metab 1990;10:13-21.
6. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997;94:5308-13.
7. 11C]methyl-tryptophan. J Cereb Blood Flow Metab 1998;18:1121-9.
8. Muzik O, Chugani DC, Chakraborty P, Mangner T, Chugani HT. Analysis of [C-11] alpha-methyl-tryplophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab 1997;17:659-69.
9. Chugani DC, Muzik O, Chakraborty P, Mangner T, Chugani HT. Human brain serotonin synthesis capacity measured in vivo with α-[C-11]methyl-L-tryptophan. Synapse 1998;28:33-43.
10. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
11. Okazawa H, Diksic M. Image generation of the serotonin synthesis rate using α-methyl-tryptophan and PET. J Comput Assist Tomogr 1998;22:777-85.
12. 1A receptors in vitro and in vivo. Eur J Nucl Med 1998;25:338-46.
13. 18F]altanserin: results in young normal controls. J Cereb Blood Flow Metab 1995;15:787-97.
14. 11C](+)McN5652. Synapse 1995;20:37-43.
15. Mück-̂eler D, Diksic M. DL-Fenfluramine increases 5-HT synthesis rate in the terminals while decreasing it in the cell bodies of the rat brain. Brain Res 1996;737:45-50.
16. Mück-̂eler D, Jevric-Causevic A, Diksic M. Influence of fluoxetine on regional serotonin synthesis in the rat brain. J Neurochem 1996;67:2434-42.
17. 1a agonist buspirone on serotonin synthesis in the rat brain. J Neurochem 1999;72:2022-31.
18. 11C]methyl-L-tryptophan method for measuring rates of serotonin synthesis in the human brain. Neuropsychopharmacology 1999;21:153-5.
19. Diksic M, Leyton M, Benkelfat C. Is α-methyl-L-tryptophan a good tracer for brain serotonin synthesis measurements, and does the lumped constant vary in different structures of the rat brain? J Neurochem 1999;73:2621-2.
20. Spitzer RL. Structured clinical interview for DSM-IIIR. New York: Biometrics Research Department, New York State Psychiatric Institute; 1987.
21. 11C]methyl-L-tryptophan for PET studies. Nucl Med Biol 1995;22:303-7.
22. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536-46.
23. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme; 1988.
24. Collins DL, Neelin P, Peter TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994;18:192-205.
25. Diksic M, Nagahiro S, Chaly T, Sourkes TL, Yamamoto YL, Feindel W. Serotonin synthesis rate measured in living dog brain by positron emission tomography. J Neurochem 1991;56:153-62.
26. Mandel AJ, Knapp S. Regulation of serotonin biosynthesis in brain: role of the high affinity uptake of tryptophan into serononergic neurons. Fed Proc 1977;36:2142-8.
27. 11C]alpha-methyl-tryptophan and positron emission tomography compared to CSF 5-hydroxyindole-3-acetic acid concentrations. Neuropsychopharmacology 1998;19:345-53.
28. Vanier M, Tsuiki K, Grdisa M, Worsley K, Diksic M. Determination of the lumped constant for the alpha-methyl-tryptophan method of estimating the rate of serotonin synthesis. J Neurochem 1995;64:624-35.
29. Shoaf SE, Schmall B. Pharmacokinetics of α-methyl-L-tryptophan in rhesus monkeys and calculation of the lumped constant for estimating the rate of serotonin synthesis. J Pharm Exp Ther 1996;277:219-24.
30. Fristen KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RSJ. The relationship between global and local changes in PET studies. J Cereb Blood Flow Metab 1990;10:458-66.
31. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690-9.
32. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametrical maps in functional imaging: a general linear approach. Hum Brain Mapping 1995;2:189-210.
33. Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapping 1994;1:210-20.
34. Åsberg M, Träskman L, Thorén P. 5-IIIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976;33:1193-7.
35. Träskman L, Åsberg M, Burtilsson L, Sjåstrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981;38:631-6.
36. Gharib A, Balende C, Sarda N, Weissmann D, Plenevaux A, Luxen A, et al. Biochemical and autoradiographic measurements of brain serotonin synthesis rate in the freely moving rat: a reexamination of the α-methyl-L-tryptophan method. J Neurochem 1999;72:2593-600.
37. Fenstermacher JD. Current models of blood-brain transfer. Trends Neurosci 1985;8:449-53.
38. 2O PET study in humans. Neurosci Lett 1996;207:25-8.
39. 11C]Doxepin. In: Carson RE, Daube-Witherspoon ME, Herscovitch P, editors. Quantitative functional brain imaging with positron emission tomography. New York: Academic Press; 1998. p. 207-14.
40. 18F]fluorodopa uptake rate using three-dimensional PET. In: Carson RE, Daube-Witherspoon ME, Herscovitch P, editors. Quantitative functional brain imaging with positron emission tomography. New York: Academic Press; 1998. p. 117-23.
41. 18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 1999;9:63-80.
42. 15O] water studies with short interscan interval for single-subject and group analysis: influence of background subtraction. J Cereb Blood Flow Metab 1998;18(4):433-43.
43. Worsley KJ, Evans AC, Marrett S, Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 1992;12:900-18.
44. Bailey DL, Jones T, Friston KJ, Colebatch JG, Frackowiak RSJ. Physical validation of statistical parametrical mapping. J Cereb Blood Flow Metab 1991;11(Suppl 2):S150.
45. Young SN, Gauthier S, Anderson GM, Purdy WC. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry 1980;43:438-45.
46. Ågren H, Mefford IN, Rudorfer MV, Linnoila M, Potter WZ. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res 1986;20:175-93.
47. Biver F, Lotstra F, Monclus M, Wikler D, Damhaut P, Mendlewicz J, et al. Sex difference in 5-HT, receptor in the living human brain. Neurosci Lett 1996;204:25-8.
48. Arato M, Frecska E, Tekes K, MacCrimmon DJ. Serotonergic interhemispheric asymmetry: gender difference in the orbital cortex. Acta Psychiatr Scand 1991;84:110-1.
49. Weissman MM, Olfson M. Depression in women: implications for health care research. Science 1995;269:799-801.
50. Bloxam WF, Curzon G. A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J Neurochem 1978;31:1255-63.
51. Salter M, Knowles RG, Pogson CI. How does displacement of albumine-bound tryptophan cause sustained increases in the free tryptophan concentration in plasma and 5-hydroxytryptamine synthesis in brain? Biochem J 1989;262:365-8.